Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.634, 2011-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Adjuvant chemotherapy beneficial in pancreatic cancer?
Inpharma, Vol. 1, Iss. 1314, 2001-01 ,pp. :
Access to resources
Recommend
Cost effectiveness of risperidone: is compliance the key?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 614, 2010-01 ,pp. :
Do physicians consider cost effectiveness in clinical practice?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 301, 2001-01 ,pp. :
Cost effectiveness of finasteride: a risky business?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 607, 2010-01 ,pp. :
ICD cost effectiveness over-rated?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 495, 2006-01 ,pp. :